NFE2L2 and chronic obstructive pulmonary disease: This enhanced Nrf2-driven antioxidant response has been shown to effectively counteract CSE-induced cellular damage in vitro and ameliorate COPD pathology in vivo, resulting in reduced oxidative injury, diminished inflammation, and improved lung function [3,[69], [70], [71]].